SoftOx Solutions AS will hold a General Meeting on 24th June 2026 at 10 am
(CEST). The notice convening the General Meeting, including the agenda and the
board's proposals for the matters to be dealt with, is enclosed with this
notification and will be sent to all shareholders.
Relevant documents referred to in the notice are also made available at
https://soft-ox.com/stock-market-announcements/
For further information, please contact:
Ulrik Spork, COB Soft Solutions AS, +45 31 38 83 87
Ingrid Juven, CFO SoftOx Solutions AS, +47 918 76 165
Mail: ir@soft-ox.com
About SoftOx Solutions AS:
SoftOx Solutions AS (ticker: SOFTX) is a clinical-stage pharmaceutical company
developing SIS (SoftOx Inhalation Solution), a novel inhaled anti-infective
therapy for the treatment of respiratory infections in the airways and lungs.
The Company is listed on Euronext Growth Oslo.
d on Euronext Growth Oslo.\